GENEVA, Aug. 31 -- NOVARTIS AG filed a patent application (IB2026/051496) for “CYCLIN-DEPENDENT KINASE (CDK2) INHIBITORS”. With publication no. WO/2026/176311, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 403/04
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....